BioNTech this week kicked off production at the Marburg, Germany, plant it acquired last year from Novartis. The plant will focus on making mRNA batches, the beginning of...
Pfizer and BioNTech are accelerating the time it takes to produce a Covid-19 vaccine batch and are aiming to almost cut it in half, Chaz Calitri, vice president of...
Expanding its supply relationship with compatriot BioNTech, Germany’s Merck said it will “significantly accelerate” the supply of urgently needed lipids to vaccine maker...
Conventional drugmakers are now responding in force to the Covid-19 vaccine challenge, teaming up on different projects with different partners, contributing expertise...
Following initial euphoria over conditional marketing approval of two Covid-19 vaccines by the European Medicines Agency (EMA) in recent weeks, EU countries are turning...
US drugmaker Pfizer and partner BioNTech have confirmed they will temporarily reduce Covid deliveries to Europe as Pfizer revamps its designated plant in Belgium to lift...
Germany’s BioNTech has scaled up its projections for the number of doses of its Covid-19 vaccine it will make this year from 1.3 billion to 2 billion, as it seeks...
Unsurprisingly in view of the surging cases of Covid-19 worldwide, there was little interruption in the flow of vaccine news – or at least talk about vaccines– during...
